![Edgar Parker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Edgar Parker
Entité | Type d'entité | Industrie | |
---|---|---|---|
PharmEng International, Inc.
![]() PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON.
12
| Extinct | Miscellaneous Commercial Services | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Edgar Parker via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Toronto | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Intelgenx Corp.
![]() Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Keata Pharma, Inc. | Chief Operating Officer President | ||
The Bank of Canada
![]() The Bank of Canada General GovernmentGovernment The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada. | General Government | Director/Board Member Corporate Officer/Principal | |
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
BDC Venture Capital
![]() BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Private Equity Investor | |
University of Western Ontario | College/University | Masters Business Admin | |
IMV INC. | Biotechnology | Director/Board Member | |
DRI Capital, Inc.
![]() DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Corporate Officer/Principal | |
Kirchner Private Capital Group
![]() Kirchner Private Capital Group Investment ManagersFinance Kirchner Private Capital Group provides merchant banking services. It offers mergers, acquisitions, and divestitures advisory; management assessment; and workouts and turnarounds management services. The firm also provides strengths, weaknesses, opportunities, and threats analysis; negotiation; and strategic planning services. The company was founded by W. B. Kirchner in 1985 and is headquartered in Gadsden, AL. | Investment Managers | Corporate Officer/Principal | |
METALO MANUFACTURING INC. | Steel | Director of Finance/CFO | |
The Institute of Chartered Accountants of Nova Scotia | Corporate Officer/Principal | ||
Pillar5 Pharma, Inc.
![]() Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Pharmaceuticals: Major | Director/Board Member | |
Radcliffe Consulting & Investment Ltd. | Chief Executive Officer | ||
INTELGENX TECHNOLOGIES CORP. | Pharmaceuticals: Major | Director/Board Member | |
Queen's University | College/University | Undergraduate Degree | |
Export Development Canada
![]() Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Finance/Rental/Leasing | Director/Board Member | |
Novartis Pharmaceuticals Canada, Inc.
![]() Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rimon Therapeutics Ltd.
![]() Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Founder | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Institute of Biomaterials & Biomedical Engineering | College/University | Corporate Officer/Principal | |
St. Mary's University | College/University | Undergraduate Degree | |
Unsworth Kachafanas
![]() Unsworth Kachafanas Miscellaneous Commercial ServicesCommercial Services Part of Nash Hannem & Associates, Unsworth Kachafanas is a Canadian company that provides accounting services. The company is based in Sydney, Canada. Unsworth Kachafanas was acquired by Nash Hannem & Associates on October 29, 2014. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PharmEng Technology, Inc.
![]() PharmEng Technology, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmEng International, Inc., PharmEng Technology, Inc. is a full-service consulting firm that serves pharmaceutical, biotechnology, and medical device industries. The company is based in Toronto, Canada. PharmEng Technology prides itself on its proven track record of excellence which ensures that all client needs and governing regulatory expectations are met and exceeded. Since 1997, the Canadian company has provided industry-recognized services to assist clients in the rapid commercialization of new products from drug discovery to strategic planning to process scale up. The company was founded in 1977 by Alan Kwong. Alan Kwong has been the CEO since 1977. | Pharmaceuticals: Major | President | |
Therapeutics Chemical Engineering Ltd. | Chief Tech/Sci/R&D Officer | ||
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
Millenium Biologix Corp.
![]() Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | President | |
Cita NeuroPharmaceuticals, Inc.
![]() Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
Trimel Capital Corp.
![]() Trimel Capital Corp. Financial ConglomeratesFinance Trimel Capital Corp. operates as a capital pool firm. It aims to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The company was founded on July 17, 2019 is headquartered in Toronto, Canada. | Financial Conglomerates | Director/Board Member | |
Steel Rail Entertainment, Inc. | Chief Executive Officer | ||
Charles H Ivey Foundation | Director/Board Member | ||
University of Guelph | College/University | Undergraduate Degree |
Statistiques
Internationale
Canada | 35 |
Etats-Unis | 5 |
France | 2 |
Sectorielle
Health Technology | 12 |
Finance | 9 |
Consumer Services | 7 |
Non-Energy Minerals | 3 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 21 |
Corporate Officer/Principal | 14 |
Undergraduate Degree | 6 |
Director of Finance/CFO | 6 |
President | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Edgar Parker
- Connexions Sociétés